Ambu A/S (LON: 0MJF)

Market Cap	4.14B
Revenue (ttm)	601.58M
Net Income (ttm)	26.22M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	157.73
Forward PE	n/a
Dividend	0.04 (0.03%)
Ex-Dividend Date	Dec 5, 2024

Volume	636,458
Average Volume	315,487
Open	136.70
Previous Close	134.05
Day's Range	136.40 - 139.15
52-Week Range	10.89 - 17.18
Beta	0.79
RSI	68.70
Earnings Date	Jan 30, 2025

About Ambu A/S

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management a...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1937
• Employees: 5,196
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0MJF

Financial Performance

In 2024, Ambu A/S's revenue was 5.39 billion, an increase of 12.90% compared to the previous year's 4.78 billion. Earnings were 235.00 million, an increase of 39.88%.

Financial numbers in DKK